Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.831 USD | +3.87% | -17.33% | -4.90% |
Jul. 01 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) dropped from Russell 3000 Index | CI |
Jun. 28 | HC Wainwright Adjusts Price Target on Karyopharm Therapeutics to $7 From $8, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.90% | 99.71M | |
+15.08% | 122B | |
+16.20% | 113B | |
+17.55% | 26.22B | |
-24.23% | 19.01B | |
-19.14% | 15.71B | |
-17.75% | 15.22B | |
-46.81% | 14.72B | |
+57.01% | 14.58B | |
+4.81% | 13.84B |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- Wedbush Trims Karyopharm Therapeutics' Price Target to $6 From $7, Keeps Neutral Rating